Key Takeaways
- • Epsilon Health, an AI-native radiology practice based in San Francisco, emerged from stealth with $27.6 million in funding, according to the company's announcement.
- • The round was led by AlleyCorp, with participation from Uncork Capital, Renegade Partners, SemperVirens, and Jack Altman, who invested while serving as Managing Partner at Alt Capital.
- • Epsilon combines artificial intelligence with physician oversight to interpret medical imaging faster and at higher quality, and is designed to integrate into existing healthcare workflows.
- • The company says it is on track to interpret 1% of all daily U.S. X-rays in 2026.
Summary
Epsilon Health, an AI-native radiology practice in San Francisco, has emerged from stealth with $27.6 million in funding. The company positions itself as reinventing how radiology is delivered, targeting what it describes as one of the most urgent crises in American healthcare.
The round was led by AlleyCorp. Uncork Capital, Renegade Partners, and SemperVirens also participated, as did Jack Altman, who invested while serving as Managing Partner at Alt Capital.
According to the company, Epsilon's model pairs artificial intelligence with physician oversight to deliver faster, higher-quality medical interpretation. The platform is built to integrate seamlessly into existing healthcare workflows rather than requiring providers to replace their systems. Epsilon states it is on track to interpret 1% of all daily U.S. X-rays in 2026.
The primary source does not disclose a valuation, a specific use of proceeds, or detailed performance metrics, so those details remain unconfirmed.
The round was led by AlleyCorp. Uncork Capital, Renegade Partners, and SemperVirens also participated, as did Jack Altman, who invested while serving as Managing Partner at Alt Capital.
According to the company, Epsilon's model pairs artificial intelligence with physician oversight to deliver faster, higher-quality medical interpretation. The platform is built to integrate seamlessly into existing healthcare workflows rather than requiring providers to replace their systems. Epsilon states it is on track to interpret 1% of all daily U.S. X-rays in 2026.
The primary source does not disclose a valuation, a specific use of proceeds, or detailed performance metrics, so those details remain unconfirmed.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.